Title : Early metabolomic profiling in IBD: Crohn's disease and ulcerative colitis patients
Abstract:
The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are complex chronic relapsing disorders with component of gut microbiome alteration. Not always standard diagnostics allow to ensure the precise diagnostics for a high-quality selection of personalized therapy in IBD. Metabolomics provides a unique opportunity to characterize disease-associated metabolic changes and may be used in quantifying gut microbial metabolism that can become a novel metabolic signature in IBD patients.
